ADC Therapeutics (ADCT) Net Cash Flow (QoQ) (2020 - 2026)
ADC Therapeutics (ADCT) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -213.90% |
| Dec 31, 2025 | 189.26% |
| Sep 30, 2025 | -142.80% |
| Jun 30, 2025 | 223.73% |
| Mar 31, 2025 | -144.24% |
| Dec 31, 2024 | 11.77% |
| Sep 30, 2024 | -139.71% |
| Jun 30, 2024 | 248.68% |
| Mar 31, 2024 | -38.51% |
| Dec 31, 2023 | 13.58% |
| Sep 30, 2023 | -200.22% |
| Jun 30, 2023 | 330.88% |
| Mar 31, 2023 | 70.76% |
| Dec 31, 2022 | -1,369.44% |
| Sep 30, 2022 | 107.98% |
| Jun 30, 2022 | -51.60% |
| Mar 31, 2022 | 44.11% |
| Dec 31, 2021 | -140.21% |
| Sep 30, 2021 | 1,507.43% |
| Jun 30, 2021 | 79.94% |